Durgical
EN
Open the app

Phototherapy and systemic treatments: what they do and how they are monitored

  • Topic

When creams are not enough, light, tablets or injections calm the immune system in psoriasis, eczema and more. Each has its own checks and risks.

Updated

See it in 3D: Skin

What it is

Extensive or severe inflammatory skin disease is treated beyond topicals with phototherapy (narrowband ultraviolet B, or psoralen plus UVA), conventional systemic drugs (methotrexate, ciclosporin, acitretin, azathioprine, mycophenolate) and targeted therapies (biologics against TNF, IL-17, IL-23 or IL-4/IL-13 signalling, and small molecules such as JAK and PDE4 inhibitors). The choice depends on the disease, its extent and impact, joints, other illnesses, pregnancy plans, infections such as tuberculosis and hepatitis, and access. Every option has known toxicities, so baseline tests and monitoring are part of the treatment.

Key facts

  • Narrowband UVB: psoriasis, atopic dermatitis, vitiligo; a course of repeated sessions in a supervised unit; risks are burning and, over many years, skin ageing and cancer.
  • Methotrexate: psoriasis and psoriatic arthritis; monitor blood count and liver; teratogenic; interacts with sulfamethoxazole-trimethoprim; its schedule differs from most drugs, and schedule errors have caused fatal toxicity, so prescriptions are double-checked.
  • Ciclosporin: fast control of severe eczema or psoriasis for short periods; monitor blood pressure and kidney function.
  • Acitretin: psoriasis; strongly teratogenic for a long time after stopping; monitor lipids and liver.
  • Biologics and JAK inhibitors: screen for latent tuberculosis and hepatitis B and C before starting; update vaccines; live vaccines are avoided during treatment.
  • IL-4/IL-13 blockade (atopic dermatitis) can cause conjunctivitis; IL-17 blockade can worsen inflammatory bowel disease.

Systemic options and what to watch

OptionMain usesKey monitoring and risks
Narrowband UVBPsoriasis, eczema, vitiligoBurns; long-term photoageing and cancer
MethotrexatePsoriasis, psoriatic arthritisBlood count, liver; teratogenic; schedule errors are dangerous
CiclosporinSevere eczema or psoriasis, short termBlood pressure, kidney function
AcitretinPsoriasisTeratogenic for years; lipids, liver
BiologicsPsoriasis, eczema, hidradenitis, urticariaLatent tuberculosis, hepatitis, infections, vaccines
JAK inhibitorsEczema, alopecia areata, vitiligo, psoriatic arthritisInfections, zoster, thrombosis, lipids, blood count

In clinical practice

  • Psoriasis with joint disease favours drugs that treat both skin and joints.
  • Systemic corticosteroids are avoided in psoriasis because of severe rebound flares when they are stopped.
  • In Colombia, latent tuberculosis screening before biologics and JAK inhibitors is essential given local tuberculosis rates.
  • Pregnancy planning shapes the choice: methotrexate and acitretin are contraindicated; acitretin's risk lasts years after stopping.

Next step

  • Before systemic treatment: blood count, liver and kidney function, lipids as relevant, pregnancy test, hepatitis B and C, HIV and latent tuberculosis screening for immunosuppressants.
  • Agree contraception where drugs are teratogenic and record it.
  • Update vaccines before immunosuppression, avoiding live vaccines once on treatment.
  • Refer to dermatology to start and monitor systemic or phototherapy treatment; refer urgently for fever, infection or abnormal monitoring results on treatment.

Common traps

  • Methotrexate follows the usual dosing schedule: its schedule differs from most drugs; schedule errors have caused fatal toxicity, so the specialist and pharmacist double-check it.
  • A biologic can start before tuberculosis screening: screen for latent tuberculosis (and hepatitis B and C) first, essential given Colombia's tuberculosis rates.
  • Systemic corticosteroids are a good fix for a psoriasis flare: they cause severe rebound flares when stopped; avoid them in psoriasis.
  • Acitretin's risk ends with the last tablet: it stays strongly teratogenic for years after stopping.

Test yourself

Think of the answer, then tap the question to see it.

Why is latent tuberculosis screening mandatory before a TNF inhibitor?

TNF holds tuberculous granulomas together; blocking it can reactivate latent tuberculosis, often in disseminated forms.

Which psoriasis drug remains teratogenic for years after stopping, and why does that matter?

Acitretin: it is stored and converted to a long-lived metabolite, so pregnancy must be avoided for years after the last dose.

Why are systemic corticosteroids avoided in psoriasis?

Stopping them can cause a severe rebound flare, sometimes pustular or erythrodermic psoriasis.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of dermatology

Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.

Sources: Psoriasis (StatPearls Publishing (NCBI Bookshelf), 2024); Plaque Psoriasis (StatPearls Publishing (NCBI Bookshelf), 2024); Atopic Dermatitis (StatPearls Publishing (NCBI Bookshelf), 2024); Psoriasis (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.